<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>Why Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>Why Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout</h1>
  <ul>
<li>Monopar Therapeutics unveiled promising results Monday from three key studies, leading the top 1% biotech stock to break out of a cup base.</li>
<li>Oops, something went wrong Monopar Therapeutics unveiled promising results Monday from three key studies, leading the top 1% biotech stock to break out of a cup base.</li>
</ul>
<p><a href="https://finance.yahoo.com/m/dd13b6bf-58fb-3ec6-8899-63efa6a71245/why-monopar-therapeutics%2C-a.html">Source</a> · 2025-09-15T20:08:46+00:00</p>
</body>
</html>